High Sierra Technologies Inc HSTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.72
- Day Range
- $1.10–1.10
- 52-Week Range
- $1.10–1.72
- Bid/Ask
- $1.05 / $1.60
- Market Cap
- $22.71 Mil
- Volume/Avg
- 100 / 100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
High Sierra Technologies Inc is a start-up that develops and expands its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry. The company owns two provisional patent applications for the production of new and novel cannabis products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.high-sierra.com
Valuation
Metric
|
HSTI
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
HSTI
Financial Strength
Metric
|
HSTI
|
---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
Interest Coverage | −3.13 |
Quick Ratio
HSTI
Profitability
Metric
|
HSTI
|
---|---|
Return on Assets (Normalized) | −468.45% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
HSTI
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Svlfmlxdp | Sxdx | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Yvtgwvdskr | Ywnstt | $71.9 Bil | |
HLN
| Haleon PLC ADR | Fvqwqcmv | Bdvx | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pzdkgjtt | Rwmj | $15.6 Bil | |
VTRS
| Viatris Inc | Wcfkzlp | Wcp | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Bmdfsdd | Wvyg | $12.5 Bil | |
CTLT
| Catalent Inc | Bnltjvrj | Ddbyyph | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Vgjfdsl | Zbzbr | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bcrmncx | Gjll | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wmvqllzgn | Cyhfqt | $3.5 Bil |